Document Type : Original Article

Authors

1 School of Medicine, Department of Cardiology, Isfahan University of Medical Sciences, Isfahan, Iran

2 Assistant Professor, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

4 Assistant Professor, Interventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

5 Assistant Professor, Department of Cardiology, Musavi hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

6 Assistant Professor, Heart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

7 Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

8 Professor, Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

9 Professor, Atherosclerosis Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

10 Professor, Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.

11 Professor, Hypertension Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran

10.48305/arya.2024.11893.0

Abstract

Abstract:

Introduction: National Persian Registry Of cardioVascular disease (N-PROVE) has been established to provide a thorough database of cardiovascular diseases in the community of Iran for further investigations and to develop national guidelines for diagnosis, treatment, and prevention of cardiovascular disease (CVD). As in most clinical registries, a quality control audit is required to provide an inclusive and accurate registry; the current study aims to assess the validity and quality of the N-PROVE/Angiography/ percutaneous coronary intervention (PCI) registry.

Methods: The current cross-sectional quality assessment study is an example of data quality assessment in N-PROVE on a sample of patients registered in the N-PROVE/Angiography/PCI registry since 2020. Accordingly, data of 199 patients, including comorbidities, angiography, and angioplasty characteristics, were gathered from N-PROVE/Angiography/PCI registry as the main database and reevaluated by a panel consisting of a cardiologist and two fellowships of coronary interventions as a test database.

Results: The quality control of the population-based healthcare database, the N-PROVE/ PCI, revealed that the average error rate in terms of comorbidities, angiography characteristics, angioplasty characteristics, and in total were 3.8%, 2.3%, 3%, and 3.03%, respectively.

Conclusion: According to the findings of this study, the N-PROVE/ PCI registry averagely had an error of less than 4% in the assessed dimensions, including comorbidities, angiography, and angioplasty characteristics. Therefore, this registry seems valid and may be used for contemporary epidemiological studies.

Keywords: Registries, Data management, Cardiovascular disease, Angiography, Angioplasty

Keywords